ARQ-761

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameARQ-761
Drug Alias NameARQ-761
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscription factor E2F1 stimulants
TargetsTranscription factor E2F1
Therapy Area/IndicationsSolid tumoursPancreatic NeoplasmsLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesArqule Inc
China Registration ClassN/A

Develop Information

Active CompaniesArqule Inc
Active IndicationsPancreatic Neoplasms
Inactive IndicationsSolid tumoursLymphoma

Other Information

ATC CodeN/A
Related LinksN/A